TENAX THERAPEUTICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
TENAX THERAPEUTICS, INC. (TENX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.10 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-11-15
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was $6.68M, a 61.02% increase year-over-year.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$1.87M.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$2.71M.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was -$1.99M.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2020 was $1.34M.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$7.46M, a 169.33% decline from fiscal 2018.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $10.76M.
- TENAX THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$8.39M, a 232.45% decline from fiscal 2016.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 8 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 530 month | Cash and Cash Equivalents, Period Increase (Decrease) 533 month | Cash and Cash Equivalents, Period Increase (Decrease) 536 month | Cash and Cash Equivalents, Period Increase (Decrease) 539 month | Cash and Cash Equivalents, Period Increase (Decrease) 542 month | Cash and Cash Equivalents, Period Increase (Decrease) 545 month | Cash and Cash Equivalents, Period Increase (Decrease) 554 month | Cash and Cash Equivalents, Period Increase (Decrease) 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | $6.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.82M derived: sum of 2 quarters · filed 2021-11-15 | $2.10M 10-Q · filed 2021-11-15 | $118.54K derived: sum of 4 quarters · filed 2021-11-15 | |||||||||
| 2021-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$4.58M 10-Q · filed 2021-08-16 | -$6.56M derived: sum of 3 quarters · filed 2021-08-16 | -$2.41M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||
| 2021-03-31 | -$2.71M 10-Q · filed 2021-05-17 | -$4.70M derived: sum of 2 quarters · filed 2021-05-17 | -$548.52K derived: sum of 3 quarters · filed 2021-11-15 | -$821.89K derived: sum of 4 quarters · filed 2021-11-15 | |||||||||
| 2020-12-31 | -$1.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $2.16M derived: sum of 2 quarters · filed 2021-11-15 | $1.89M derived: sum of 3 quarters · filed 2021-11-15 | $1.34M 10-K/A · filed 2021-04-16 | |||||||||
| 2020-09-30 | $4.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.88M derived: sum of 2 quarters · filed 2021-11-15 | $3.33M 10-Q · filed 2021-11-15 | $1.59M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||
| 2020-06-30 | -$273.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$820.69K 10-Q · filed 2021-08-16 | -$2.56M derived: sum of 3 quarters · filed 2021-08-16 | -$4.32M derived: sum of 4 quarters · filed 2021-08-16 | |||||||||
| 2020-03-31 | -$547.31K 10-Q · filed 2021-05-17 | -$2.29M derived: sum of 2 quarters · filed 2021-05-17 | -$4.05M derived: sum of 3 quarters · filed 2021-05-17 | -$5.96M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||
| 2019-12-31 | -$1.74M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | -$3.50M derived: sum of 2 quarters · filed 2021-04-16 | -$5.42M derived: sum of 3 quarters · filed 2021-04-16 | -$7.46M 10-K/A · filed 2021-04-16 | |||||||||
| 2019-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$3.67M derived: sum of 2 quarters · filed 2020-11-16 | -$5.72M 10-Q · filed 2020-11-16 | $3.30M derived: sum of 4 quarters · filed 2020-11-16 | |||||||||
| 2019-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$3.96M 10-Q · filed 2020-08-14 | $5.06M derived: sum of 3 quarters · filed 2020-08-14 | $4.50M derived: sum of 4 quarters · filed 2020-08-14 | |||||||||
| 2019-03-31 | -$2.05M 10-Q · filed 2020-05-15 | $6.98M derived: sum of 2 quarters · filed 2020-05-15 | $6.42M derived: sum of 3 quarters · filed 2020-05-15 | $7.33M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||
| 2018-12-31 | $9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $8.46M derived: sum of 2 quarters · filed 2020-03-30 | $9.37M derived: sum of 3 quarters · filed 2020-03-30 | $10.76M 10-K · filed 2020-03-30 | |||||||||
| 2018-09-30 | -$555.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $353.94K derived: sum of 2 quarters · filed 2019-11-14 | $1.74M 10-Q · filed 2019-11-14 | $1.58M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||
| 2018-06-30 | $909.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $2.30M 10-Q · filed 2019-08-14 | $2.14M derived: sum of 3 quarters · filed 2019-08-14 | $1.67M derived: sum of 4 quarters · filed 2019-08-14 | |||||||||
| 2018-03-31 | $1.39M 10-Q · filed 2019-05-15 | $1.23M derived: sum of 2 quarters · filed 2019-05-15 | $759.55K derived: sum of 3 quarters · filed 2019-05-15 | -$4.04M derived: sum of 4 quarters · filed 2019-05-15 | |||||||||
| 2017-12-31 | -$159.07K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$628.88K derived: sum of 2 quarters · filed 2019-04-01 | -$5.42M derived: sum of 3 quarters · filed 2019-04-01 | -$8.39M 10-K · filed 2019-04-01 | |||||||||
| 2017-09-30 | -$469.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$5.26M derived: sum of 2 quarters · filed 2018-11-14 | -$8.23M 10-Q · filed 2018-11-14 | $1.04M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||
| 2017-06-30 | -$4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$7.76M 10-Q · filed 2018-08-14 | $1.51M derived: sum of 3 quarters · filed 2018-08-14 | $305.66K derived: sum of 4 quarters · filed 2018-08-14 | |||||||||
| 2017-03-31 | -$2.97M 10-Q · filed 2018-05-15 | $6.31M derived: sum of 2 quarters · filed 2018-05-15 | $5.10M derived: sum of 3 quarters · filed 2018-05-15 | $3.77M derived: sum of 4 quarters · filed 2018-05-15 | |||||||||
| 2016-12-31 | $9.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $8.07M derived: sum of 2 quarters · filed 2018-04-02 | $6.73M derived: sum of 3 quarters · filed 2018-04-02 | $6.34M 10-K · filed 2018-04-02 | |||||||||
| 2016-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$2.54M derived: sum of 2 quarters · filed 2017-11-09 | -$2.94M 10-Q · filed 2017-11-09 | ||||||||||
| 2016-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.73M 10-Q · filed 2017-08-09 | |||||||||||
| 2016-03-31 | -$397.94K 10-Q · filed 2017-05-10 | ||||||||||||
| 2015-12-31 | -$4.27M 10-K · filed 2017-03-16 | ||||||||||||
| 2015-10-31 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | -$2.83M 10-Q · filed 2015-12-10 | |||||||||||
| 2015-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$8.56M 10-Q · filed 2016-11-09 | |||||||||||
| 2015-07-31 | -$4.28M 10-Q · filed 2015-09-09 | ||||||||||||
| 2015-06-30 | -$4.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$4.99M 10-Q · filed 2016-08-09 | |||||||||||
| 2015-04-30 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$50.39M 10-K · filed 2017-03-16 | |||||||||||
| 2015-03-31 | -$919.87K 10-Q · filed 2016-05-10 | ||||||||||||
| 2015-01-31 | -$4.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$12.04M derived: sum of 2 quarters · filed 2015-12-10 | -$48.41M 10-Q · filed 2015-03-17 | $3.58M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-10-31 | -$7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | -$43.96M 10-Q · filed 2015-12-10 | $8.02M derived: sum of 3 quarters · filed 2017-03-16 | $11.81M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-07-31 | -$36.36M 10-Q · filed 2015-09-09 | $15.62M derived: sum of 2 quarters · filed 2017-03-16 | $19.41M derived: sum of 3 quarters · filed 2017-03-16 | $17.88M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-04-30 | $51.98M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $55.78M derived: sum of 2 quarters · filed 2017-03-16 | $54.25M derived: sum of 3 quarters · filed 2017-03-16 | $57.54M 10-K · filed 2017-03-16 | |||||||||
| 2014-01-31 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $2.27M derived: sum of 2 quarters · filed 2015-03-17 | $5.56M 10-Q · filed 2015-03-17 | $5.51M derived: sum of 4 quarters · filed 2016-03-14 | $6.34M 10-Q · filed 2014-03-17 | ||||||||
| 2013-10-31 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $1.76M 10-Q · filed 2014-12-15 | $1.71M derived: sum of 3 quarters · filed 2016-03-14 | $1.03M derived: sum of 4 quarters · filed 2016-03-14 | $2.54M 10-Q · filed 2013-12-17 | ||||||||
| 2013-07-31 | $3.29M 10-Q · filed 2014-09-15 | $3.24M derived: sum of 2 quarters · filed 2016-03-14 | $2.56M derived: sum of 3 quarters · filed 2016-03-14 | $1.38M derived: sum of 4 quarters · filed 2016-03-14 | $4.07M 10-Q · filed 2013-09-17 | ||||||||
| 2013-04-30 | -$45.28K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | -$727.99K derived: sum of 2 quarters · filed 2016-03-14 | -$1.91M derived: sum of 3 quarters · filed 2016-03-14 | -$1.10M 10-KT · filed 2016-03-14 | $783.53K 10-K · filed 2013-06-26 | ||||||||
| 2013-01-31 | -$682.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | -$1.86M derived: sum of 2 quarters · filed 2014-03-17 | -$1.05M 10-Q · filed 2014-03-17 | -$2.45M derived: sum of 4 quarters · filed 2014-03-17 | $828.81K 10-Q · filed 2013-03-18 | ||||||||
| 2012-10-31 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | -$368.36K 10-Q · filed 2013-12-17 | -$1.77M derived: sum of 3 quarters · filed 2013-12-17 | -$492.74K derived: sum of 4 quarters · filed 2013-12-17 | $1.51M 10-Q · filed 2012-12-14 | ||||||||
| 2012-07-31 | $811.26K 10-Q · filed 2013-09-17 | -$590.37K derived: sum of 2 quarters · filed 2013-09-17 | $686.87K derived: sum of 3 quarters · filed 2013-09-17 | -$1.31M derived: sum of 4 quarters · filed 2013-09-17 | $2.69M 10-Q · filed 2012-09-19 | ||||||||
| 2012-04-30 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | -$124.39K derived: sum of 2 quarters · filed 2013-06-26 | -$2.12M derived: sum of 3 quarters · filed 2013-06-26 | $927.93K 10-K · filed 2013-06-26 | $1.88M 10-K · filed 2012-07-25 | ||||||||
| 2012-01-31 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | -$716.64K derived: sum of 2 quarters · filed 2013-03-18 | $2.33M 10-Q · filed 2013-03-18 | $2.76M derived: sum of 4 quarters · filed 2013-03-18 | $3.28M 10-Q · filed 2012-03-15 | ||||||||
| 2011-10-31 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | $1.05M 10-Q · filed 2012-12-14 | $1.48M derived: sum of 3 quarters · filed 2012-12-14 | $1.17M derived: sum of 4 quarters · filed 2012-12-14 | $2.00M 10-Q · filed 2011-12-15 | ||||||||
| 2011-07-31 | $3.05M 10-Q · filed 2012-09-19 | $3.48M derived: sum of 2 quarters · filed 2012-09-19 | $3.16M derived: sum of 3 quarters · filed 2012-09-19 | $1.27M derived: sum of 4 quarters · filed 2012-09-19 | $4.00M 10-Q · filed 2011-09-19 | ||||||||
| 2011-04-30 | $429.60K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $114.78K derived: sum of 2 quarters · filed 2012-07-25 | -$1.78M derived: sum of 3 quarters · filed 2012-07-25 | $319.24K 10-K · filed 2012-07-25 | |||||||||
| 2011-01-31 | -$314.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | -$2.21M derived: sum of 2 quarters · filed 2012-03-15 | -$110.37K 10-Q · filed 2012-03-15 | ||||||||||
| 2010-10-31 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $204.46K 10-Q · filed 2011-12-15 | |||||||||||
| 2010-07-31 | $2.10M 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |